0.5759
price down icon7.56%   -0.0541
 
loading

Kineta Inc Aktie (KA) Neueste Nachrichten

Kineta Inc Inc. (KA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

pulisher
The InvestChronicle

Quarterly Snapshot: Quick and Current Ratios for Kineta Inc (KA) – DWinneX - The Dwinnex

pulisher
The Dwinnex

Check Out Kineta Inc (KA)’s Trade Data Rather Than the Analysts’ Views - SETE News

pulisher
SETE News

A look at KA's current quarter earnings estimates – US Post News - US Post News

pulisher
US Post News

Kineta Inc Inc. (KA) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle

pulisher
The InvestChronicle

KA Shares Experience Surge in Value – Knox Daily - Knox Daily

pulisher
Knox Daily

KA’s Stock Market Pendulum: Swinging Between Gains and Losses - The InvestChronicle

pulisher
The InvestChronicle

Quarterly Metrics: Quick and Current Ratios for Kineta Inc (KA) – DWinneX - The Dwinnex

pulisher
The Dwinnex

Quarterly Metrics: Quick and Current Ratios for Kineta Inc (KA) – DWinneX - The Dwinnex

pulisher
The Dwinnex

Kineta reports progress in cancer therapy trials By Investing.com - Investing.com

pulisher
Investing.com

Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical ... - wallstreet:online

pulisher
wallstreet:online

Kineta Reports First Quarter 2024 Financial Results and Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical ... - wallstreet:online

pulisher
wallstreet:online

Kineta: Q1 Earnings Snapshot - Houston Chronicle

pulisher
Houston Chronicle

BioWorld Cancer Index ends Q1 up on pipeline progress, despite restructurings - BioWorld Online

pulisher
BioWorld Online

Kineta (NASDAQ:KA) Stock Price Down 7.4% - Defense World

pulisher
Defense World

Why Wang & Lee Group Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket - Adaptive ... - Benzinga

pulisher
Benzinga

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket

pulisher
Benzinga

Why Medical Properties Trust Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Markets Insider

pulisher
Markets Insider

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session

pulisher
Benzinga

Why Ascent Solar Technologies Shares Are Trading Lower By Around 50%? Here Are Other Stocks Moving In ... - Markets Insider

pulisher
Markets Insider

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday's Mid-Day ... - Markets Insider

pulisher
Markets Insider

Kineta Reports Progress in KVA12123 Cancer Trial - TipRanks.com - TipRanks

pulisher
TipRanks

Kineta Reports Initial Clinical Response Data at AACR 2024 of its Ongoing Phase 1/2 VISTA-101 Clinical Trial

pulisher
GlobeNewswire Inc.

Kineta reports positive trial results for cancer therapy By Investing.com - Investing.com

pulisher
Investing.com

Kineta Reports Full Year 2023 Financial Results and Provides Corporate Update

pulisher
GlobeNewswire Inc.

KA Stock Quote Price and Forecast - CNN

pulisher
CNN

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session

pulisher
Benzinga

Why SOPHiA GENETICS Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Tuesday's Mid-Day ... - Markets Insider

pulisher
Markets Insider

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

pulisher
Benzinga

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day ... - Benzinga

pulisher
Benzinga

S&P 500 Moves Higher; Hayward Holdings Shares Jump On Upbeat Results

pulisher
Benzinga

Why Butterfly Network Shares Are Trading Lower By 22%? Here Are Other Stocks Moving In Thursday's Mid-Day Session

pulisher
Benzinga

Crude Oil Moves Higher; Best Buy Posts Upbeat Earnings

pulisher
Benzinga

Kineta Weighs Strategic Alternatives Amid Operational Challenges - TipRanks.com - TipRanks

pulisher
TipRanks

Kineta CEO laid off as cutbacks leave biotech with 4 employees - The Business Journals

pulisher
The Business Journals

Kineta to Present New Preclinical Data on its Anti-VISTA Antibody KVA12123 in Acute Myeloid Leukemia at the AACR Blood Cancer Discovery Symposium

pulisher
GlobeNewswire Inc.

Kineta to Present at Upcoming Investor Conferences

pulisher
GlobeNewswire Inc.

Kineta Provides Update on its Ongoing Phase 1/2 VISTA-101 Clinical Trial of KVA12123 in Patients with Advanced Solid Tumors

pulisher
GlobeNewswire Inc.

Kineta to Participate in the 13th Annual LifeSci Partners Corporate Access Event

pulisher
GlobeNewswire Inc.

Kineta to Present at the Life Sciences Investor Forum December 14th - Financial Post

pulisher
Financial Post

KA: Autumn Activity - Yahoo Finance

pulisher
Yahoo Finance

Insider Buying: Thierry Guillaudeux Acquires 10,000 Shares of Kineta Inc - Yahoo Finance

pulisher
Yahoo Finance

Seattle biotech firm Kineta averts Nasdaq stock delisting - Puget Sound Business Journal - The Business Journals

pulisher
The Business Journals

Selection waits on efficacy data from trial of Kv1.3 ion channel blocker in atopic dermatitis - BioWorld Online

pulisher
BioWorld Online

Kineta Stock (NASDAQ:KA), Quotes and News Summary - Benzinga

pulisher
Benzinga

Merck Officially Commences $1.36B Imago Buyout - BioSpace

pulisher
BioSpace

Yumanity Therapeutics Declares Special Dividend In Connection with Proposed Asset Sale to Janssen and Merger ... - GlobeNewswire

pulisher
GlobeNewswire

Kineta, Merck Strike Deal to Pair Anti-VISTA Antibody with Keytruda - BioSpace

pulisher
BioSpace

Kineta Announces Participation in the H.C. Wainwright 24th Annual Global Healthcare Conference - PR Newswire

pulisher
PR Newswire
$146.84
price down icon 2.64%
$84.97
price down icon 0.08%
$25.73
price down icon 0.16%
$84.20
price down icon 2.90%
$447.85
price down icon 0.91%
$248.02
price up icon 3.29%
Kapitalisierung:     |  Volumen (24h):